Myovant Sciences Ltd 's

• MYOV's Stock Performance relative to its Competitors

Sunshine Biopharma Inc Share Performance -18.57% 30 Days

Sunshine Biopharma Inc Profile Sunshine Biopharma Inc is a pharmaceutical company that focuses on developing and commercializing drugs for the treatment of cancer and other diseases. They utilize their expertise in drug discovery and development to create innovative treatments that target specific molecular targets in order to deliver more effective and personalized therapies for patients. More about Sunshine Biopharma Inc 's Market Share

Protagonist Therapeutics inc Share Performance +52.73% This Quarter

Protagonist Therapeutics inc Profile Protagonist Therapeutics Inc's business model focuses on the development and commercialization of novel peptide-based therapeutics. More about Protagonist Therapeutics inc 's Market Share

Ptc Therapeutics inc Share Performance -9.70% This Year

Ptc Therapeutics inc Profile PTC Therapeutics Inc's business model revolves around the research, development, and commercialization of innovative treatments for rare and genetic diseases. More about Ptc Therapeutics inc 's Market Share

Puretech Health Plc Share Performance +1.15% Over The Past 5 Days

Puretech Health Plc Profile Puretech Health Plc is a biotechnology company that operates a unique business model focusing on innovation and entrepreneurship. They identify and validate disruptive technologies and build and invest in companies around those technologies, with a focus on identifying unmet medical needs. By developing a diversified portfolio of cutting-edge healthcare companies, Puretech aims to deliver breakthrough therapies to improve patient outcomes. More about Puretech Health Plc's Market Share

Prothena Corporation Public Limited Company Share Performance +14.45% 30 Days

Prothena Corporation Public Limited Company Profile Prothena Corporation is a biotechnology company that focuses on developing novel therapies for diseases related to protein misfolding and amyloidosis. Their business model includes leveraging their expertise in antibody and protein engineering to develop and commercialize drug candidates, collaborating with pharmaceutical partners to advance their therapeutic programs, and continuously conducting research and development to expand their pipeline of potential treatments. Their goal is to address unmet medical needs and provide innovative solutions for patients suffering from devastating diseases. More about Prothena Corporation Public Limited Company's Market Share

Sources: Myovant Sciences Ltd’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Tuesday, September 8, 2026 1:22 AM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Myovant Sciences Ltd versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.